A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma ; volume:3 ; number:1 ; day:26 ; month:7 ; year:2005 ; pages:1-15 ; date:12.2005
Journal of translational medicine ; 3, Heft 1 (26.7.2005), 1-15, 12.2005
- Urheber
-
Geiger, Christiane
- Beteiligte Personen und Organisationen
-
Regn, Sybille
Weinzierl, Andreas
Noessner, Elfriede
Schendel, Dolores J.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-3-29
- URN
-
urn:nbn:de:1111-2016041431026
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Geiger, Christiane
- Regn, Sybille
- Weinzierl, Andreas
- Noessner, Elfriede
- Schendel, Dolores J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells
Dendritic cells
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells
Dendritic Cell‐Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells
Dendritic cells
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells
Dendritic Cell‐Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
T-Cell stimulation by melanoma RNA-pulsed dendritic cells
Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells
Dendritic cells
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number
Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells